Biomarkers in early-stage colorectal cancer: ready for prime time?
BACKGROUND/AIMS: During the last two decades, hundreds of reports have detailed putative prognostic and predictive biomarkers for colorectal cancer (CRC). However, the majority of these studies have been small and retrospective, reporting results that are highly likely to represent false positives....
Principais autores: | Church, D, Midgley, R, Kerr, D |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
2012
|
Registros relacionados
-
Adjuvant chemotherapy for stage II colorectal cancer: the time is right!
por: Midgley, R, et al.
Publicado em: (2005) -
The emergence of 'omics for the management of colorectal cancer.
por: Midgley, R, et al.
Publicado em: (2011) -
Adjuvant chemotherapy for stage II colorectal cancer: who should receive therapy and with what?
por: Midgley, R, et al.
Publicado em: (2005) -
Circulating tumor DNA in early-stage colon cancer: ready for prime time or needing refinement?
por: Joao Paulo Solar Vasconcelos, et al.
Publicado em: (2022-12-01) -
Immunotherapy for colorectal cancer.
por: Midgley, R, et al.
Publicado em: (2003)